Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Food Funct ; 12(7): 3096-3103, 2021 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-33720258

RESUMEN

INTRODUCTION: Coconut oil has been considered as a therapeutic alternative in several pathologies, but there is limited information regarding its effects on brain functioning. OBJECTIVE: This study analyzed whether early virgin coconut oil (VCO) supplementation interferes with electrical activity of the adult rat brain and its lipid peroxidation. Moreover, it investigated whether the putative effect on brain electrophysiology could be affected by overnutrition occurring during lactation, and/or by environmental enrichment (EE). Electrophysiology was measured through cortical spreading depression (CSD), a phenomenon related to brain excitability. METHODS: Wistar rats were suckled in litters of either nine or three pups, forming nourished (N) or overnourished (ON) groups, respectively. Between the 7th and 30th days of life, half of the animals in each group received VCO (10 mg kg-1 d-1; by gavage). The other half received an equivalent amount of vehicle (V, 0.009% cremophor). On day 36, animals from both groups were subjected to EE for 4 weeks. At 105 ± 15 days of life, each animal was subjected to CSD recordings and lipid peroxidation analyses. RESULTS: Overnutrition during lactation enhanced body and brain weights. VCO decelerated the CSD propagation velocity (control - 3.57 ± 0.23 mm min-1versus VCO - 3.27 ± 0.18 mm min-1; p < 0.001), regardless of whether subjected to overnourishment or EE exposure. Neither VCO nor EE modified the cerebral lipid peroxidation (p > 0.05). CONCLUSION: VCO supplementation impaired the spreading of CSD, indicating reduction of brain excitability. VCO effects occurred regardless of the nutritional state during lactation.


Asunto(s)
Aceite de Coco/administración & dosificación , Depresión de Propagación Cortical/efectos de los fármacos , Animales , Suplementos Dietéticos , Modelos Animales de Enfermedad , Estado Nutricional , Fitoterapia , Ratas , Ratas Wistar
2.
Nutr Neurosci ; 24(2): 130-139, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31030633

RESUMEN

Sepsis is a clinical syndrome with high morbidity and mortality. It is characterized by acute inflammatory response and oxidative stress, which is implicated in cerebral dysfunction. Murici (Byrsonimacrassifolia (L.) Kunth) is a fruit rich in antioxidant compounds, which could be an alternative to prevent damage to tissues induced by sepsis . Here, we evaluated the effects of sepsis on the propagation of cortical spreading depression (CSD) and oxidative stress, and tested the action of murici antioxidant extract in prevention against the effect of sepsis. Male Wistar rats (90-210 days, n = 40) were previously supplemented, orogastrically, with murici extract (150 mg/kg/day or 300 mg/kg/day), or an equivalent volume of the vehicle solution, for fifteen days. Then the animals were subjected to experimental sepsis through cecal ligation and perforation (CLP). Subsequently, CSD recordings were obtained and brain oxidative stress was evaluated. Sepsis decelerated CSD and increased the malondialdehyde (MDA) levels in the brain cortex of the animals. In contrast, septic rats that had been previously supplemented with murici antioxidant extract in doses of 150 and 300 mg/kg/day showed an increase in CSD propagation velocity, low levels of MDA and GSH/GSSG ratio and an increase of superoxide dismutase (SOD) activity, regardless of the dose tested. Our results demonstrate that sepsis affects brain excitability and that this effect can be prevented by murici antioxidant extract. The effects of sepsis and/or murici extract on CSD may be due to the oxidative state of the brain.


Asunto(s)
Antioxidantes/administración & dosificación , Depresión de Propagación Cortical/efectos de los fármacos , Sepsis/fisiopatología , Animales , Frutas/química , Masculino , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Ratas Wistar
3.
Nutr Neurosci ; 24(5): 363-370, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-31221041

RESUMEN

Objectives: Pyridoxine plays a key role in the development of the human nervous system. Several reports suggest that administration of high doses of pyridoxine can be helpful in improving disturbances such as anxiety and pyridoxine-dependent epilepsy, although it has also been associated with a proconvulsive action. In this study, we investigated in developing rats the effects of repeated administration of various doses of pyridoxine on anxiety-like behavior and the brain excitability-related phenomenon known as cortical spreading depression (CSD).Methods: From postnatal day (P) 7 to P27, Wistar rat pups received per gavage pyridoxine hydrochloride (1 mg/kg/day, or 5 mg/kg/day, or 10 mg/kg/day). On P60-70, the animals were tested in the elevated plus maze (EPM) to evaluate anxiety-like behavior. On P71-80, we recorded the CSD (4-hour recording session).Results: Compared with naïve (gavage-free) and saline-treated controls, pyridoxine-treated groups displayed a significant (p < 0.001) increase in CSD propagation velocity and amplitude of the CSD negative direct-current (DC)-shift, and a decrease in the CSD DC-shift duration. These effects were long-lasting and dose-dependent. In the EPM, no significant pyridoxine-associated effect was observed.Discussion: Our data demonstrate a novel action of pyridoxine on an electrical activity-related phenomenon (CSD) in the developing brain, confirming the hypothesis that the chronic treatment with pyridoxine early in life modulates CSD. Data on CSD propagation suggest that pyridoxine at a high dose might act as a prooxidant agent in the developing brain, a hypothesis that deserves further testing.


Asunto(s)
Ansiedad/fisiopatología , Encéfalo/efectos de los fármacos , Encéfalo/fisiopatología , Depresión de Propagación Cortical/efectos de los fármacos , Piridoxina/administración & dosificación , Animales , Animales Recién Nacidos , Conducta Animal/efectos de los fármacos , Masculino , Ratas Wistar
4.
Food Chem Toxicol ; 133: 110783, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31491430

RESUMEN

Migraine is one of the most common neurological disorder, which has long been related to brain serotonin (5-HT) depletion and neuro-inflammation. Despite many treatment options are available, the frequent occurrence of unacceptable adverse effects further supports the research toward nutraceuticals and herbal preparations, among which Tanacetum parthenium and Salix alba showed promising anti-inflammatory and neuro-modulatory activities. The impact of extract treatment on astrocyte viability, spontaneous migration and apoptosis was evaluated. Anti-inflammatory/anti-oxidant effects were investigated on isolated rat cortexes exposed to a neurotoxic stimulus. The lactate dehydrogenase (LDH) release, nitrite levels and 5-HT turnover were evaluated, as well. A proteomic analysis was focused on specific neuronal proteins and a fingerprint analysis was carried out on selected phenolic compounds. Both extracts appeared able to exert in vitro anti-oxidant and anti-apoptotic effects. S. alba and T. parthenium extracts reduced LDH release, nitrite levels and 5-HT turnover induced by neurotoxic stimulus. The downregulation of selected proteins suggest a neurotoxicity, which could be ascribed to an elevated content of gallic acid in both S. alba and T. parthenium extracts. Concluding, both extracts exert neuroprotective effects, although the downregulation of key proteins involved in neuron physiology suggest caution in their use as food supplements.


Asunto(s)
Antioxidantes/farmacología , Trastornos Migrañosos/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Extractos Vegetales/farmacología , Salix/química , Tanacetum parthenium/química , Animales , Antioxidantes/toxicidad , Apoptosis/efectos de los fármacos , Artemia/efectos de los fármacos , Línea Celular , Corteza Cerebral/efectos de los fármacos , Depresión de Propagación Cortical/efectos de los fármacos , Fármacos Neuroprotectores/toxicidad , Extractos Vegetales/toxicidad , Ratas Sprague-Dawley , Cicatrización de Heridas/efectos de los fármacos
5.
Biochem Biophys Res Commun ; 508(2): 445-450, 2019 01 08.
Artículo en Inglés | MEDLINE | ID: mdl-30503503

RESUMEN

Propranolol, a ß-adrenergic receptor blocker, is one of the most commonly used prophylactic drugs for migraines. Cortical spreading depression (CSD) is the propagation wave of neuronal excitation along with cerebral blood flow (CBF) changes over the cerebral cortex and has been implicated in the pathological process of migraine auras and its pain response. However, the effect of propranolol on CSD-related CBF changes and behavioral responses remains poorly understood. In this study, we measured CSD-related CBF responses using a micro-device with a green light emitting diode (LED) and micro-complementary-metal-oxide-semiconductor (CMOS) image sensor and evaluated pain-related reduced locomotor activity in mice. An injection of KCl into the visual cortex led to CSD-related CBF changes; however, propranolol prevented the increase in CBF as well as delayed the propagation velocity in KCl-induced CSD. Furthermore, an injection of KCl reduced locomotor activity and induced freezing behavior in awake and freely moving mice, which were prevented by propranolol treatment. These results suggest that the modulation of CSD-related CBF responses by the blockade of ß-adrenergic receptor contributes to its prophylactic effects on migraines.


Asunto(s)
Circulación Cerebrovascular/efectos de los fármacos , Trastornos Migrañosos/prevención & control , Propranolol/farmacología , Antagonistas Adrenérgicos beta/farmacología , Animales , Depresión de Propagación Cortical/efectos de los fármacos , Modelos Animales de Enfermedad , Masculino , Ratones , Ratones Endogámicos C57BL , Trastornos Migrañosos/diagnóstico por imagen , Trastornos Migrañosos/fisiopatología , Actividad Motora/efectos de los fármacos , Dolor/tratamiento farmacológico , Dolor/fisiopatología , Cloruro de Potasio/administración & dosificación
6.
Acta Cir Bras ; 33(6): 472-482, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30020308

RESUMEN

PURPOSE: To investigate the effects of Murici extract on the brain excitability-dependent phenomenon known as cortical spreading depression (CSD) and on brain oxidative stress. METHODS: Adult and aged Wistar rats were supplemented with murici extract (150 mg/kg/day or 300 mg/kg/day) by gavage for fifteen days. Afterwards, the animals were submitted to a CSD electrophysiological recording and to brain oxidative stress evaluation. RESULTS: Our results showed that aging decreased CSD propagation velocity, catalase activity and glutathione/oxidized glutathione ratio (GSH/GSSG) in the brain cortex of the rats, and increased malondialdehyde (MDA) concentrations and superoxide dismutase (SOD) activity. The highest dose (300 mg/kg/day) of murici extract accelerated CSD, whereas the lowest (150mg/kg/day) decelerated, in both adult and aged animals. In contrast, aged animals supplemented with murici extract in both doses presented low MDA levels and high GSG/GSSG ratio in comparison to the control-aged animals. CONCLUSION: Murici extract supplementation seems to revert detrimental effects in aged brains and could be considered as a strategy in the treatment of pathologies related to aging and cortical spreading depression.


Asunto(s)
Envejecimiento/fisiología , Antioxidantes/farmacología , Corteza Cerebral/efectos de los fármacos , Depresión de Propagación Cortical/efectos de los fármacos , Malpighiaceae/química , Estrés Oxidativo/efectos de los fármacos , Factores de Edad , Animales , Catalasa/análisis , Corteza Cerebral/metabolismo , Depresión de Propagación Cortical/fisiología , Suplementos Dietéticos , Glutatión/análisis , Disulfuro de Glutatión/análisis , Peroxidación de Lípido , Masculino , Malondialdehído/análisis , Estrés Oxidativo/fisiología , Ratas Wistar , Valores de Referencia , Reproducibilidad de los Resultados , Superóxido Dismutasa/análisis
7.
Acta cir. bras ; 33(6): 472-482, June 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-949356

RESUMEN

Abstract Purpose: To investigate the effects of Murici extract on the brain excitability-dependent phenomenon known as cortical spreading depression (CSD) and on brain oxidative stress. Methods: Adult and aged Wistar rats were supplemented with murici extract (150 mg/kg/day or 300 mg/kg/day) by gavage for fifteen days. Afterwards, the animals were submitted to a CSD electrophysiological recording and to brain oxidative stress evaluation. Results: Our results showed that aging decreased CSD propagation velocity, catalase activity and glutathione/oxidized glutathione ratio (GSH/GSSG) in the brain cortex of the rats, and increased malondialdehyde (MDA) concentrations and superoxide dismutase (SOD) activity. The highest dose (300 mg/kg/day) of murici extract accelerated CSD, whereas the lowest (150mg/kg/day) decelerated, in both adult and aged animals. In contrast, aged animals supplemented with murici extract in both doses presented low MDA levels and high GSG/GSSG ratio in comparison to the control-aged animals. Conclusion: Murici extract supplementation seems to revert detrimental effects in aged brains and could be considered as a strategy in the treatment of pathologies related to aging and cortical spreading depression.


Asunto(s)
Animales , Masculino , Envejecimiento/fisiología , Corteza Cerebral/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Malpighiaceae/química , Antioxidantes/farmacología , Valores de Referencia , Depresión de Propagación Cortical/efectos de los fármacos , Depresión de Propagación Cortical/fisiología , Superóxido Dismutasa/análisis , Peroxidación de Lípido , Catalasa/análisis , Corteza Cerebral/metabolismo , Reproducibilidad de los Resultados , Factores de Edad , Ratas Wistar , Estrés Oxidativo/fisiología , Disulfuro de Glutatión/análisis , Suplementos Dietéticos , Glutatión/análisis , Malondialdehído/análisis
8.
Nutr Neurosci ; 21(10): 753-760, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28784045

RESUMEN

OBJECTIVES: To evaluate how safflower oil (SFO) influences brain electrophysiology and cortical oxidative status in the offspring, mothers received a diet with SFO during brain development period. METHODS: Beginning on the 14th day of gestation and throughout lactation, rats received safflower (safflower group - SG) or soybean oil (control group - CG) in their diet. At 65 days old, cortical spreading depression (CSD) and cortex oxidative status were analyzed in the offspring. RESULTS: SG presented reduction of the CSD velocity as compared to the CG (SG: 3.24 ± 0.09; CG: 3.37 ± 0.07 mm/min). SFO reduced levels of lipid peroxidation by 39.4%. SG showed the following increases: glutathione-S-transferase, 40.8% and reduced glutathione, 34.3%. However, SFO decreased superoxide dismutase by 40.4% and catalase by 64.1%. To control for interhemispheric effects, since CSD was recorded only in the right cortex, we evaluated the oxidative status in both sides of the cortex; no differences were observed. DISCUSSION: Data show that when SFO is consumed by the female rats during pregnancy and lactation, the offspring present long-term effects on brain electrophysiology and cortical oxidative state. The present study highlights the relevance of understanding the SFO intake of pregnant and lactating mammals.


Asunto(s)
Encéfalo/efectos de los fármacos , Carthamus tinctorius/química , Lactancia , Aceite de Cártamo/farmacología , Animales , Encéfalo/metabolismo , Catalasa/metabolismo , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Depresión de Propagación Cortical/efectos de los fármacos , Femenino , Glutatión/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Embarazo , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo
9.
Headache ; 57(9): 1340-1358, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28842982

RESUMEN

Migraine is among the most prevalent and disabling neurological diseases in the world. Cortical spreading depression (SD) is an intense wave of neuronal and glial depolarization underlying migraine aura, and a headache trigger, which has been used as an experimental platform for drug screening in migraine. Here, we provide an overview of novel therapeutic targets that show promise to suppress SD, such as acid-sensing ion channels, casein kinase Iδ, P2X7-pannexin 1 complex, and neuromodulation, and outline the experimental models and essential quality measures for rigorous and reproducible efficacy testing.


Asunto(s)
Depresión de Propagación Cortical/efectos de los fármacos , Sistemas de Liberación de Medicamentos/métodos , Trastornos Migrañosos/fisiopatología , Trastornos Migrañosos/terapia , Analgésicos/administración & dosificación , Animales , Anticonvulsivantes/administración & dosificación , Antidepresivos/administración & dosificación , Depresión de Propagación Cortical/fisiología , Evaluación Preclínica de Medicamentos/métodos , Cefalea/diagnóstico , Cefalea/fisiopatología , Cefalea/terapia , Humanos , Trastornos Migrañosos/diagnóstico , Neurotransmisores/administración & dosificación , Estimulación del Nervio Vago/métodos
10.
Nutr Neurosci ; 20(2): 127-134, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25138625

RESUMEN

OBJECTIVES: The potential use of garlic for prevention and treatment of different types of headaches has been suggested by several medieval literatures. Cortical spreading depression (CSD), a propagating wave of neuroglial depolarization, was established as a target for anti-migraine drugs. This study was designed to investigate the effect of garlic extract on CSD in adult rats. METHODS: CSD was induced by KCl microinjection in the somatosensory cortex. The effects of five different concentrations of garlic oil (1-500 µl/l) were tested on different characteristic features of CSD in necocortical slices. In in vivo experiments, the effects of garlic oil on electrophysiological and morphological changes induced by CSD were investigated. RESULTS: Garlic oil in a dose-dependent manner decreased the amplitude of CSD but not its duration and velocity in neocortical brain slices. Garlic oil at concentration of 500 µl/l reversibly reduced the amplitude of the field excitatory post-synaptic potentials and inhibited induction of long-term potentiation in the third layer of neocortical slices. In in vivo studies, systemic application of garlic oil (1 ml/l) for three consecutive days reduced the amplitude and repetition rate of CSD. Garlic oil also prevented of CSD-induced reactive astrocytosis in the neocortex. DISCUSSION: Garlic oil suppresses CSD, likely via inhibition of synaptic plasticity, and prevents its harmful effects on astrocyte. Further studies are required to identify the exact active ingredient(s) of garlic oil that inhibit CSD and may have the potential to use in treatment of CSD-related disorders.


Asunto(s)
Compuestos Alílicos/farmacología , Depresión de Propagación Cortical/efectos de los fármacos , Ajo/química , Neocórtex/efectos de los fármacos , Neuronas/efectos de los fármacos , Extractos Vegetales/farmacología , Corteza Somatosensorial/efectos de los fármacos , Sulfuros/farmacología , Compuestos Alílicos/administración & dosificación , Analgésicos no Narcóticos/administración & dosificación , Analgésicos no Narcóticos/farmacología , Animales , Astrocitos/citología , Astrocitos/efectos de los fármacos , Astrocitos/patología , Astrocitos/fisiología , Tamaño de la Célula/efectos de los fármacos , Etnofarmacología , Gliosis/patología , Gliosis/prevención & control , Técnicas In Vitro , Inyecciones Intraperitoneales , Medicina Tradicional , Neocórtex/citología , Neocórtex/patología , Neocórtex/fisiología , Plasticidad Neuronal/efectos de los fármacos , Neuronas/citología , Neuronas/patología , Neuronas/fisiología , Concentración Osmolar , Extractos Vegetales/administración & dosificación , Raíces de Plantas/química , Ratas , Corteza Somatosensorial/citología , Corteza Somatosensorial/patología , Corteza Somatosensorial/fisiología , Sulfuros/administración & dosificación
11.
J Cereb Blood Flow Metab ; 37(5): 1735-1747, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-27381828

RESUMEN

We examined in live coronal slices from rat and mouse which brain regions generate potassium-triggered spreading depolarization (SDKt). This technique simulates cortical spreading depression, which underlies migraine aura in the intact brain. An SDKt episode was evoked by increasing bath [K+]o and recorded as a propagating front of elevated light transmittance representing transient neuronal swelling in gray matter of neocortex, hippocampus, striatum, and thalamus. In contrast, SDKt was not imaged in hypothalamic nuclei or brainstem with exception of those nuclei near the dorsal brainstem surface. In rat slices, single neurons were whole-cell current clamped during SDKt. "Higher" neurons depolarized to near zero millivolts indicating SDKt generation. In contrast, seven types of neurons in hypothalamus and brainstem only slowly depolarized without generating SDKt, supporting our imaging findings. Therefore, SDKt is not a default of CNS neurons but rather displays a region-specific susceptibility, similar to anoxic depolarization, which we have proposed is correlated with a region's vulnerability to traumatic brain injury. In the higher brain, SDKt may be a vestigial spreading depolarization that originally evolved to shut down and vasoconstrict gray matter regions more exposed to impact and contusion.


Asunto(s)
Encéfalo/fisiopatología , Depresión de Propagación Cortical/efectos de los fármacos , Imagen Óptica , Cloruro de Potasio/farmacología , Animales , Encéfalo/diagnóstico por imagen , Encéfalo/efectos de los fármacos , Tronco Encefálico/diagnóstico por imagen , Tronco Encefálico/efectos de los fármacos , Tronco Encefálico/fisiopatología , Depresión de Propagación Cortical/fisiología , Medios de Cultivo , Hipotálamo/diagnóstico por imagen , Hipotálamo/efectos de los fármacos , Hipotálamo/fisiopatología , Técnicas In Vitro , Masculino , Potenciales de la Membrana/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Neuronas/efectos de los fármacos , Neuronas/fisiología , Técnicas de Placa-Clamp , Ratas , Ratas Sprague-Dawley
12.
J Cereb Blood Flow Metab ; 37(5): 1791-1802, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-27037093

RESUMEN

During brain damage and ischemia, the cytokine interleukin-1ß is rapidly upregulated due to activation of inflammasomes. We studied whether interleukin-1ß influences cortical spreading depolarization, and whether lipopolysaccharide, often used for microglial stimulation, influences cortical spreading depolarizations. In anaesthetized rats, cortical spreading depolarizations were elicited by microinjection of KCl. Interleukin-1ß, the IL-1 receptor 1 antagonist, the GABAA receptor blocker bicuculline, and lipopolysaccharide were administered either alone or combined (interleukin-1ß + IL-1 receptor 1 antagonist; interleukin-1ß + bicuculline; lipopolysaccharide + IL-1 receptor 1 antagonist) into a local cortical treatment area. Using microelectrodes, cortical spreading depolarizations were recorded in a non-treatment and in the treatment area. Plasma extravasation in cortical grey matter was assessed with Evans blue. Local application of interleukin-1ß reduced cortical spreading depolarization amplitudes in the treatment area, but not at a high dose. This reduction was prevented by IL-1 receptor 1 antagonist and by bicuculline. However, interleukin-1ß induced pronounced plasma extravasation independently on cortical spreading depolarizations. Application of lipopolysaccharide reduced cortical spreading depolarization amplitudes but prolonged their duration; EEG activity was still present. These effects were also blocked by IL-1 receptor 1 antagonist. Interleukin-1ß evokes changes of neuronal activity and of vascular functions. Thus, although the reduction of cortical spreading depolarization amplitudes at lower doses of interleukin-1ß may reduce deleterious effects of cortical spreading depolarizations, the sum of interleukin-1ß effects on excitability and on the vasculature rather promote brain damaging mechanisms.


Asunto(s)
Permeabilidad Capilar/fisiología , Corteza Cerebral/irrigación sanguínea , Depresión de Propagación Cortical/fisiología , Interleucina-1beta/fisiología , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Animales , Bicuculina/farmacología , Permeabilidad Capilar/efectos de los fármacos , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/fisiopatología , Depresión de Propagación Cortical/efectos de los fármacos , Depresión de Propagación Cortical/inmunología , Relación Dosis-Respuesta a Droga , Electrocorticografía , Electroencefalografía , Inflamasomas/efectos de los fármacos , Interleucina-1beta/farmacología , Lipopolisacáridos/farmacología , Masculino , Cloruro de Potasio/farmacología , Ratas Wistar , Receptores de Interleucina-1/antagonistas & inhibidores , Proteínas Recombinantes/farmacología
13.
Schizophr Res ; 165(2-3): 157-62, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25957485

RESUMEN

BACKGROUND: Cortical inhibition (CI) deficits have been demonstrated in schizophrenia using transcranial magnetic stimulation (TMS). These CI deficits may be related to decreased GABA activity which may be involved in schizophrenia pathophysiology. Previous cross-sectional studies have also demonstrated greater CI in patients treated with clozapine than other typical/atypical antipsychotics. However, it is not clear if these differences in CI are a result of treatment-resistant illness which necessitates clozapine or are related to clozapine treatment. METHODS: TMS measures of CI (i.e., cortical silent period (CSP) and short-interval cortical inhibition (SICI)) were measured over the motor cortex in 16 patients with schizophrenia before starting clozapine, then 6 weeks and 6 months after starting clozapine. RESULTS: CSP was significantly longer after 6 weeks of treatment with clozapine (p=0.014). From 6 weeks to 6 months, there was no significant difference in CSP (p>0.05). Short-interval cortical inhibition (SICI) was not significantly different at any time after treatment with clozapine (p>0.05). CONCLUSIONS: This prospective-longitudinal study demonstrates that treatment with clozapine is associated with an increase in GABAB mediated inhibitory neurotransmission. Potentiation of GABAB may be a novel neurotransmitter mechanism that is involved in the pathophysiology and treatment of schizophrenia.


Asunto(s)
Clozapina/uso terapéutico , Depresión de Propagación Cortical/efectos de los fármacos , Antagonistas del GABA/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/patología , Ácido gamma-Aminobutírico/metabolismo , Adulto , Análisis de Varianza , Relación Dosis-Respuesta a Droga , Electromiografía , Potenciales Evocados Motores/efectos de los fármacos , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Corteza Motora/fisiopatología , Escalas de Valoración Psiquiátrica , Estimulación Magnética Transcraneal , Adulto Joven
14.
Nutr Neurosci ; 18(7): 307-15, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24819023

RESUMEN

OBJECTIVE: To evaluate in adult rats, previously suckled under favorable and unfavorable conditions, the brain electrophysiological and microglial effects of the treatment early in life with the lectin (ConA) from Canavalia ensiformis. METHODS: Male Wistar newborn rats (n = 89) were suckled under favorable or unfavorable conditions, represented by litters with 6-7 pups or 12-14 pups (groups N6 and N12, respectively). From postnatal days 5-24, they were treated intraperitoneally with 1 or 10 mg/kg ConA (groups L1 and L10, respectively), or with saline solution (group Sal), or no treatment (group Naïve). At 90-120 days of age, cortical spreading depression (CSD) was recorded at two parietal points for 4 hours, and CSD parameters (velocity of propagation and amplitude and duration of the DC slow potential change) were measured. Fixative-perfused brain sections were reacted with anti-Iba1 antibodies to quantify immunolabeled microglia. RESULTS: Compared with the control groups, ConA-treated animals dose-dependently presented with reduced CSD propagation velocities and increased amplitude and duration of the CSD slow potential change. Microglia Iba-1 immunoreactivity was lower in both nutritional groups treated with ConA, in comparison with the control groups. The CSD hemisphere presented with higher immunoreactivity compared with the CSD-free hemisphere. DISCUSSION: Attenuation in CSD propagation and microglia reaction was associated in adulthood with ConA treatment during brain development, indicating that the lectin can affect the electrophysiological and microglial development, and suggesting long-lasting protective action of the lectin on the rat brain, which is not impeded by the unfavorable suckling condition.


Asunto(s)
Canavalia/química , Depresión/prevención & control , Lectinas/farmacología , Microglía/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Animales Recién Nacidos , Peso Corporal , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Proteínas de Unión al Calcio/metabolismo , Depresión de Propagación Cortical/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Fenómenos Electrofisiológicos/efectos de los fármacos , Inmunohistoquímica , Masculino , Proteínas de Microfilamentos/metabolismo , Microglía/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Conformación Proteica , Ratas , Ratas Wistar
15.
Biochim Biophys Acta ; 1820(10): 1490-5, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22659523

RESUMEN

BACKGROUND: Conjugated linoleic acids (CLA) are fatty acids that are found in the lipids from goat milk, and appear to protect neurons from excitotoxicity. METHODS: We investigated in developing rats the effects of a maternal CLA-rich diet (containing 7% lipids from goat milk) on body development and cerebral electrical activity of the progeny from dams receiving the CLA diet during gestation (G), lactation (L) or both periods (G+L). RESULTS: Compared to a control group (C) receiving a diet with 7% soybean oil, body weight increased at 14, 21 and 28 days, but not at 35-45 days, in L and G+L groups (P<0.05). No intergroup difference was found on body and brain weights, body length, abdominal and thoracic circumferences, body mass index and abdominal to thoracic circumference ratio at 35-45 days. In contrast, at this later age the CSD velocities of propagation were significantly higher (P<0.05) in L as compared with the C and G group, and in the L+G, as compared with the C, G and L groups, suggesting a long-lasting brain effect. CONCLUSION: These data indicate that a maternal CLA-rich diet can differentially influence body weight increment (short-term effect), and CSD propagation (long-term effect) in the progeny, and the lactation is the most critical period for such diet actions. GENERAL SIGNIFICANCE: The facilitating effect of the lipids from goat milk on an excitability-related phenomenon in the brain (CSD) can be of clinical relevance, since CSD has been associated to neurological disturbances like migraine and epilepsy.


Asunto(s)
Depresión de Propagación Cortical/efectos de los fármacos , Grasas Insaturadas en la Dieta/farmacología , Crecimiento/efectos de los fármacos , Ácidos Linoleicos Conjugados/farmacología , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Animales , Animales Recién Nacidos/crecimiento & desarrollo , Animales Recién Nacidos/fisiología , Encéfalo/efectos de los fármacos , Encéfalo/crecimiento & desarrollo , Encéfalo/metabolismo , Química Encefálica/efectos de los fármacos , Dieta , Ácidos Grasos/análisis , Ácidos Grasos/metabolismo , Femenino , Masculino , Fenómenos Fisiologicos Nutricionales Maternos/efectos de los fármacos , Embarazo , Efectos Tardíos de la Exposición Prenatal/etiología , Efectos Tardíos de la Exposición Prenatal/psicología , Ratas , Ratas Wistar
16.
Life Sci ; 85(5-6): 241-7, 2009 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-19508874

RESUMEN

AIMS: Glutamine (Gln) participates in the so-called "brain glutamine-glutamate cycle" and therefore it is likely to influence brain excitability. Here we investigated, in weaned well-nourished and early-malnourished rats, the effects of previous Gln oral supplementation, during the brain development period, on cortical spreading depression (CSD), an excitability-related brain phenomenon. MAIN METHODS: Male Wistar (W) suckling rat pups, well-nourished (litters with 6 pups) and malnourished (M) during lactation (by increasing the litters to 12 pups), received Gln (500 mg/kg/day) by gavage during postnatal days 7 to 27. At 30-40 days of life, they were submitted to a cortical spreading depression (CSD) recording session during 4 h, on 2 cortical parietal points of the right hemisphere. CSD velocity propagation was calculated from the time required for a CSD wave to cross the inter-electrode distance. KEY FINDINGS: In both nutritional condition, Gln rats presented higher (p<0.05) CSD propagation velocities (W-Gln, 4.22+/-0.23; M-Gln, 4.51+/-0.27 mm/min), as compared to water-treated controls (W-Wa, 3.77+/-0.21; M-Wa, 4.15+/-0.18 mm/min). This water control group did not differ from a naive control group that was not submitted to the gavage procedure. A fourth group, treated with a "placebo amino acid" (glycine), also displayed CSD velocities in the control range. SIGNIFICANCE: The results indicate that Gln supplementation during brain development facilitates cortical spreading depression propagation, as judged by the higher CSD velocities, and this effect is not abolished by malnutrition. Data support the idea of Gln-related changes in brain excitability, during neural development.


Asunto(s)
Encéfalo/efectos de los fármacos , Depresión de Propagación Cortical/efectos de los fármacos , Glutamina/administración & dosificación , Lactancia/fisiología , Desnutrición/fisiopatología , Administración Oral , Animales , Animales Lactantes , Encéfalo/crecimiento & desarrollo , Encéfalo/fisiopatología , Depresión de Propagación Cortical/fisiología , Electroencefalografía , Masculino , Desnutrición/complicaciones , Ratas
17.
J Neurosci ; 28(32): 8014-24, 2008 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-18685026

RESUMEN

Spreading depression (SD) is wave of profound depolarization that propagates throughout brain tissue and can contribute to the spread of injury after stroke or traumatic insults. The contribution of Ca(2+) influx to SD differs depending on the stimulus, and we show here that Zn(2+) can play a critical complementary role in murine hippocampal slices. In initial studies, we used the Na(+)/K(+) ATPase inhibitor ouabain and found conditions in which SD was always prevented by L-type Ca(2+) channel blockers; however, Ca(2+) influx was not responsible for L-type effects. Cytosolic Ca(2+) increases were not detectable in CA1 neurons before SD, and removal of extracellular Ca(2+) did not prevent ouabain-SD. In contrast, cytosolic Zn(2+) increases were observed in CA1 neurons before ouabain-SD, and L-type channel block prevented the intracellular Zn(2+) rises. A slow mitochondrial depolarization observed before ouabain-SD was abolished by L-type channel block, and Zn(2+) accumulation contributed substantially to initial mitochondrial depolarizations. Selective chelation of Zn(2+) with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) abolished SD, implying that Zn(2+) entry can play a critical role in the generation of ouabain-SD. TPEN was most effective when synaptic activity was reduced by adenosine A(1) receptor activation, and a combination of Ca(2+) and Zn(2+) removal was required to prevent ouabain-SD when A(1) receptors were blocked. Similarly, Zn(2+) chelation could prevent SD triggered by oxygen/glucose deprivation but Zn(2+) accumulation did not contribute to SD triggered by localized high K(+) exposures. These results identify Zn(2+) as a new target for the block of spreading depolarizations after brain injury.


Asunto(s)
Depresión de Propagación Cortical/fisiología , Hipocampo/fisiología , Zinc/metabolismo , Antagonistas del Receptor de Adenosina A1 , Animales , Calcio/metabolismo , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo L/metabolismo , Quelantes/farmacología , Depresión de Propagación Cortical/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Electrofisiología , Inhibidores Enzimáticos/farmacología , Etilenodiaminas/farmacología , Glucosa/deficiencia , Hipocampo/metabolismo , Hipoxia/fisiopatología , Técnicas In Vitro , Masculino , Potenciales de la Membrana , Ratones , Ratones Endogámicos , Mitocondrias/fisiología , Ouabaína/farmacología , Potasio/administración & dosificación , Potasio/farmacología , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores
18.
Neurosci Lett ; 434(1): 66-70, 2008 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-18281154

RESUMEN

The ketogenic diet (KD) is a high fat and low carbohydrate and protein diet. It is used in the clinical treatment of epilepsy, in order to decrease cerebral excitability. KD is usually composed by long-chain triglycerides (LCT) while medium-chain triglycerides (MCT) diet is beginning to be used in some clinical treatment of disorders of pyruvate carboxylase enzyme and long-chain fatty acid oxidation. Our study aimed to analyze the effects of medium- and long-chain KD on cerebral electrical activity, analyzing the propagation of the phenomenon of cortical spreading depression (CSD). Three groups of weaned rats (21 days old) received, for 7 weeks, either a control (AIN-93G diet), or a MCT-KD (rich in triheptanoin oil), or a LCT-KD (rich in soybean oil). They were compared to another three groups (21 days old) receiving the same diets for just 10 days. CSD propagation was evaluated just after ending the dietary treatments. Results showed that short-term KD treatment resulted in a significant reduction of the CSD velocity of propagation (control group: 4.02+/-1.04mm/min; MCT-KD: 0.81+/-1.46mm/min and LCT-KD: 2.26+/-0.41mm/min) compared to the control group. However, long-term treatment with both KDs had no effect on the CSD velocity (control group: 3.10+/-0.41mm/min, MCT-KD: 2.91+/-1.62mm/min, LCT-KD: 3.02+/-2.26mm/min) suggesting that both short-term KDs have a positive effect in decreasing brain cerebral excitability in young animals. These data show for the first time that triheptanoin has an effect on central nervous system.


Asunto(s)
Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Depresión de Propagación Cortical/efectos de los fármacos , Grasas de la Dieta/farmacología , Triglicéridos/metabolismo , Triglicéridos/farmacología , Animales , Corteza Cerebral/fisiopatología , Depresión de Propagación Cortical/fisiología , Grasas de la Dieta/uso terapéutico , Suplementos Dietéticos/normas , Modelos Animales de Enfermedad , Esquema de Medicación , Potenciales Evocados/efectos de los fármacos , Potenciales Evocados/fisiología , Ácidos Grasos/metabolismo , Alimentos Formulados/normas , Ácidos Heptanoicos/metabolismo , Ácidos Heptanoicos/farmacología , Ácidos Heptanoicos/uso terapéutico , Cetonas/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Metabolismo de los Lípidos/fisiología , Masculino , Ratas , Ratas Wistar , Aceite de Soja/metabolismo , Aceite de Soja/farmacología , Aceite de Soja/uso terapéutico , Resultado del Tratamiento , Triglicéridos/uso terapéutico
19.
Brain Res ; 1069(1): 207-15, 2006 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-16380097

RESUMEN

In neonates, asphyxia is usually followed by hyperoxic treatment. In order to study whether hyperoxic reoxygenation might cause additional impairment of neuronal function, we subjected organotypic hippocampal slice cultures of juvenile rats (7 DIV, P6-8) to 30 min anoxia followed by 60 min hyperoxic or normoxic reoxygenation (95% or 19% O2, respectively). Spontaneous and evoked field potentials as well as [Ca2+]o were recorded in the pyramidal layer of area CA1 or area CA3. In area CA1, 30 min of anoxia led to decline of evoked field potential amplitudes by on average 67% and to profound changes in field potential characteristics and Ca2+ homeostasis which were not related to outcome after reoxygenation. Hyperoxic reoxygenation resulted first in a fast recovery of the field potential amplitude to 82% of the control value and then, in 75% of slice cultures, in a large negative field potential shift accompanied by a prolonged decrease of [Ca2+]o and loss of excitability outlasting the experiment. Recovery of field potential amplitude under normoxic conditions stayed poor, with a first increase to 51% and a second decrease to 22%. In contrast, field potential amplitude in area CA3 recovered to 80% of the initial amplitude, irrespective of the reoxygenation mode. The selective loss of function during hyperoxic reoxygenation in area CA1 might be a first sign of neuronal injury that we observed 1 h after end of hyperoxic reoxygenation in a previous study. Whether the poor outcome after normoxic reoxygenation would favour long-term recovery remains to be determined.


Asunto(s)
Potenciales Evocados/efectos de los fármacos , Hipocampo/patología , Hipoxia/fisiopatología , Neuronas/efectos de los fármacos , Oxígeno/farmacología , Animales , Animales Recién Nacidos , Calcio/metabolismo , Distribución de Chi-Cuadrado , Depresión de Propagación Cortical/efectos de los fármacos , Depresión de Propagación Cortical/fisiología , Depresión de Propagación Cortical/efectos de la radiación , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica/métodos , Potenciales Evocados/fisiología , Potenciales Evocados/efectos de la radiación , Hipocampo/fisiopatología , Oxigenoterapia Hiperbárica/métodos , Neuronas/fisiología , Neuronas/efectos de la radiación , Técnicas de Cultivo de Órganos , Ratas , Ratas Wistar , Factores de Tiempo
20.
Brain Res ; 1028(1): 83-91, 2004 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-15518645

RESUMEN

Spreading depression (SD) propagates in cortical regions that are different in their morphological and functional characteristics. We tested whether the propagation pattern of spreading depression was different between parts of the cortex. In six adult rats, we recorded the ECoG by a 4 x 4 electrode array that covered parts of the frontal, parietal cortex and the cingulate cortex. Simultaneously a 16-channel magnetoencephalogram was recorded to characterize the development and direction of intracortical ion movements accompanying this phenomenon. Spreading depression was initiated by occipital application of 0.3 molar KCl solution. Depolarization was observed, at first, at lateral cortical regions and then at medial cortical regions. Thereafter, the propagation velocity increased in medial cortical regions and was faster than in lateral regions. Negative potential shifts were detected by all electrodes, but the depolarization reached a maximum over lateral and caudal cortical regions. The recorded magnetic fields indicated the same orientation of currents underlying these fields, which was perpendicular to the wave front and points away from the depolarization region. Overall, the data indicated that propagation patterns of spreading depression differed between parts of the cortex and, thus, propagation was inhomogeneous. This propagation was accompanied by strong currents parallel to the cortical surface.


Asunto(s)
Mapeo Encefálico , Depresión de Propagación Cortical/fisiología , Lóbulo Frontal/fisiología , Giro del Cíngulo/fisiología , Potenciales de la Membrana/fisiología , Lóbulo Parietal/fisiología , Animales , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/fisiología , Depresión de Propagación Cortical/efectos de los fármacos , Electroencefalografía , Lóbulo Frontal/efectos de los fármacos , Giro del Cíngulo/efectos de los fármacos , Magnetoencefalografía , Potenciales de la Membrana/efectos de los fármacos , Lóbulo Parietal/efectos de los fármacos , Potasio/farmacología , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA